期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性ST段抬高型心肌梗死患者围术期阿托伐他汀的应用观察 被引量：5

原文传递
导出
摘要 急性心肌梗死（acutemyocardialinfarction，AMI）是指在冠状动脉病变的基础上，发生冠状动脉血供的急剧下降或中断，使相应的心肌发生严重而持久的急性缺血，从而导致心肌细胞坏死的病理生理过程。AMI发病危急凶险，病死率居高不下。而如何优化AMI的治疗一直是临床的热门课题。
作者 林冬铭 黄抒伟 窦丽萍 徐长福 陆明 车庆
机构地区 浙江中医药大学附属第二医院心内科
出处 《中华危重症医学杂志（电子版）》 CAS 2014年第6期50-52,共3页 Chinese Journal of Critical Care Medicine:Electronic Edition
基金 浙江省医学会临床科研基金项目(2009ZYC007)
关键词 心肌梗死患者 急性心肌梗死 ST段抬高型 阿托伐他汀 围术期 冠状动脉病变 应用 病理生理过程
分类号 R542.22 [医药卫生—心血管疾病]
  • 相关文献

参考文献13

  • 1Cannon CP, Braunwald E, McCabe CH, et al. Inten?sive versus moderate lipid lowering with statins after acute coronary syndromes[J]. N Engl J Med, 2004, 350 (15): 1495-1504.
  • 2Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined -a consensus document of The 10int European Society of Cardiology / American College of Cardiology Committee for the redefinition of myocardial infarction.[J]. 1 Am ColI Cardiol, 2000, 36 (3): 959-969.
  • 3Pasceri V, Patti G, Nusca A, et al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention:results from the ARMYDA (atorvastatin for reduction of myocardial damage during angioplasty) study[J]. Circulation, 2004, 110 (6): 674- 678.
  • 4Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial[J]. J Am ColI Cardiel, 2007, 49 (12): 1272-1278.
  • 5Di Sciascia G, Patti G, Pasceri V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (atorvastatin for reduction of myocardial damage during angioplasty) randomized trial[J]. J Am ColI Cardio, 2009, 54 (6): 558-565.
  • 6Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression coronary at herosclerosis:a randomised cont rolled trial[J]. JAMA, 2004, 291 (9): 1071-1080.
  • 7Silva M, Matthews ML, Jarvis C, et al. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy[J]. Clin Ther, 2007, 29 (2): 253-260.
  • 8Athyros VG, Mikhailidis DP, Liberopoulos EN, et al. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek atorvastatin and coronary heart disease evaluation (GREACE) study[J]. Nephrol Dial Transplant, 2007, 22 (1): 118-127.
  • 9曾家顺,李龙.阿托伐他汀对活化蛋白-1和转化生长因子-β_1在糖尿病大鼠肾组织表达的影响[J].中国医院药学杂志,2008,28(18):1566-1569. 被引量：5
  • 10Patti G, Chello M, Pasceri V, et al. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (atorvastatin for reduction of myocardial damage during angioplasty-cell adhesion molecules) substudy[J]. J Am Coil Cardiol, 2006, 48 (8): 1560-1566.

二级参考文献25

共引文献19

同被引文献28

引证文献5

二级引证文献24

中华危重症医学杂志（电子版）
2014年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部